Company Overview and News

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

Headline News

ARQL / ArQule, Inc. 8-K (Current Report)

2018-02-22 sec.gov
    SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549   FORM 8-K   CURRENT REPORT   Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 16, 2018   ARQULE, INC. (Exact Name of Issuer as Specified in Charter)   Delaware 000-21429 04-3221586 (State or other jurisdiction (Commission File Number) (I.R.S. Employer of incorporation)   Identification No. (9-0)

Top Analyst Upgrades and Downgrades: Alkermes, ArQule, Bluebird Bio, Cognizant, Ecolab, KLA-Tencor, Pandora, Verisk, Vonage and More

2018-02-22 247wallst
The stock market has demonstrated that perhaps the return of volatility is real after Wednesday’s big gains suddenly turned into a big loss in the final 30 minutes of trading. Now stocks are indicated just marginally higher after digesting more of the verbiage from the FOMC minutes yesterday. With the bull market approaching nine years old, the trend that has worked without fail for roughly six years has been to buy the dips every time. (46-2)

ARQL / ArQule, Inc. / Nantahala Capital Management, LLC - SC 13G/A (Passive Investment)

2018-02-14 sec.gov
      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13G   Under the Securities Exchange Act of 1934 (Amendment No. 3)*   ArQule, Inc. (Name of Issuer)   Common Stock, $0.01 par value (Title of Class of Securities)   04269E107 (CUSIP Number)   December 31, 2017 (Date of Event which Requires Filing of this Statement)     Check the appropriate box to designate the rule pursuant to which this Schedule is filed:     x  Rule 13d-1(b) ¨  Rule 13d-1(c) ¨  Rule 13d-1(

ARQL / ArQule, Inc. / Nantahala Capital Management, LLC - SC 13G/A (Passive Investment)

2018-02-14 sec.gov
      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13G   Under the Securities Exchange Act of 1934 (Amendment No. 3)*   ArQule, Inc. (Name of Issuer)   Common Stock, $0.01 par value (Title of Class of Securities)   04269E107 (CUSIP Number)   December 31, 2017 (Date of Event which Requires Filing of this Statement)     Check the appropriate box to designate the rule pursuant to which this Schedule is filed:     x  Rule 13d-1(b) ¨  Rule 13d-1(c) ¨  Rule 13d-1(

Week In Review: Tsinghua University Invests $276 Million In Cambridge U.K. Biohub

2018-02-11 seekingalpha
Tsinghua University Holdings (TUS) of Beijing will invest $276 million to build a new biohub in the UK's Cambridge Science Park. The biohub will be a joint venture between TUS and Trinity College, Cambridge, the owner of the park. The money will build five new buildings, comprising 350,000 square feet. This includes a state-of-the-art biohub, which will provide labs and offices for early stage companies working on a wide range of healthcare technologies, including non-invasive diagnostics, new drugs, novel surgical techniques, and new home-monitoring technologies. (80-2)

BRIEF-Roivant Sciences And Arqule Enter Into License Agreement For Derazantinib In China

2018-02-07 reuters
* ARQULE INC - ‍DEAL TERMS INCLUDE AN UPFRONT PAYMENT TO ARQULE OF $3 MILLION AND AN ADDITIONAL $2.5 MILLION DEVELOPMENT MILESTONE WITHIN FIRST YEAR​ (9-0)

ARQL / ArQule, Inc. FORM 8-K (Current Report)

2018-02-07 sec.gov
        UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549   FORM 8-K   CURRENT REPORT  PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934   Date of report (Date of earliest event reported): February 2, 2018   ARQULE, INC. (Exact name of registrant as specified in its charter)   Delaware 000-21429 04-3221586 (State or other jurisdiction of incorporation) (Commission File Number) (I.

ARQL / ArQule, Inc. / First Eagle Investment Management, LLC - 3G/A (Passive Investment)

2018-02-06 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 3) (RULE 13d-102) Information to be included in statements filed pursuant to Rule 13d-1 (b) (c) and (d) and Amendments thereto filed pursuant to Rule 13d-2 (b). ArQule, Inc. (Name of Issuer) Common shares (Title of Class of Securities) 04269E107 (CUSIP/SEDOL Number) February 1, 2018 (Date of Event which Requires Filing of this Statement) Check the approp

ARQL / ArQule, Inc. / First Eagle Investment Management, LLC - 3G/A (Passive Investment)

2018-02-06 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 3) (RULE 13d-102) Information to be included in statements filed pursuant to Rule 13d-1 (b) (c) and (d) and Amendments thereto filed pursuant to Rule 13d-2 (b). ArQule, Inc. (Name of Issuer) Common shares (Title of Class of Securities) 04269E107 (CUSIP/SEDOL Number) February 1, 2018 (Date of Event which Requires Filing of this Statement) Check the approp

ROTY Edition 1 Volume 76: How To Deal With Market Selloffs And Spring Cleaning For The Contenders List

2018-02-06 seekingalpha
Readers are encouraged to make their voices heard in my recent blog post if they haven´t already. (647-3)

Galectin Therapeutics (GALT) Jumps: Stock Rises 15.1%

2017-12-28 zacks
Galectin Therapeutics Inc. (GALT - Free Report) was a big mover last session, as the company saw its shares rise more than 15% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $1.54 to $2.98 in the past one-month time frame. (147-0)

ARQL / ArQule, Inc. RDER

2017-12-15 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION December 12, 2017 ORDER GRANTING CONFIDENTIAL TREATMENT UNDER THE SECURITIES EXCHANGE ACT OF 1934 ArQule, Inc. File No. 0-21429 - CF#35681 _____________________ ArQule, Inc. submitted an application under Rule 24b-2 requesting confidential treatment for information it excluded from the Exhibits to a Form 10-Q filed on November 9, 2017.

ROTY Edition 1 Volume 62: (More) ASH Updates And Trades

2017-12-13 seekingalpha
ASH was a mixed bag for us at ROTY, but I´m glad readers got to see both sides of the coin. (156-1)

ROTY Edition 1 Volume 59: Updates And Trades

2017-12-07 seekingalpha
December had a decidedly rough start for the biotech sector and ROTY, which I discuss below. (102-3)

ARQL / ArQule, Inc. FORM S-3

2017-12-06 sec.gov
    As Filed with the Securities and Exchange Commission on December 6, 2017   Registration No. 333-               UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549       FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933       ARQULE, INC. (Exact name of registrant as specified in its charter)       DELAWARE (State or other jurisdiction of incorporation or organization)   04-3221586 (IRS Employer Identification No.


CUSIP: 04269E107